Abstract
During the process of evaluating the role of peptides in the control of motility of the canine gastrointestinal tract (Daniel et al. 1983), we commenced the practise of testing the response of all agonists during both quiescence and during regular phasic activity either spontaneous or induced by field stimulation or intraarterial injection of motilin (Fox et al. 1984). This revealed new profoundly inhibitory actions of a number of agents which had previously seemed to have exclusively excitatory actions. These included acetylcholine (Fox et al. 1983 b; Fox et al. 1985), substance P (Fox et al. 1983 a; Fox and Daniel 1985), bombesin/gastrin-releasing peptide (GRP) (Fox and McDonald 1984), and the putative M1 muscarinic receptor agonist McNeil A 343 (Fox et al. 1985). Pharmacological studies have suggested that these agonists produce inhibition by activating directly (acetylcholine and McNeil A 343) or indirectly (substance P and GRP) a muscarinic M1 inhibitory receptor located in the myenteric plexus. The evidence for this hypothesis is summarized below.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Daniel EE, Gandu T, Damoto T, Oki M, Yanaihara N (1982) The effects of substance P and met5 enkephalin in dog ileum. Can J Physiol Pharmacol 60: 830–840.
Daniel EE, Fox JET, Oki M, Donoto T, Sakai Y, Yanaihara W, Tack NS (1983) Study of peptides in control of motility. In: Chey WY (ed) Functional disorders of the digestive tract. Raven, New York, pp 103–112.
Daniel EE, Costa M, Furness JB, Keast JR (1985) Peptide neurons in the canine small intestine. J Comp Neurol (to be published).
Fox JET, Daniel EE (1985) Substance P: a potent inhibitor of the canine small intestine in vivo. Am J Physiol (to be published).
Fox JET, McDonald TJ (1984) Motor effects of gastrin releasing peptide (GRP) and bombesin in the canine stomach and small intestine. Life Sci 35: 1667–1673.
Fox JET, Daniel EE, Jury J (1983a) Substance P (SP): a participant in the inhibitory “brake” mechanism of canine small intestine. In: Skrabenek P, Powell D (eds) Substance P. Dublin 1983. Boole, Dublin, pp 105–106.
Fox JET, Daniel EE, McDonald TJ, Jury J, Robotham KH (1983b) Evidence for a muscarinic brake activated by peptides in the canine small intestine. In: Roman C (ed) Gastrointestinal motility. MTP Press, Lancaster, pp 327–333.
Fox JET, Daniel EE, Jury J, Robotham H (1984) The mechanism of motilin excitation of the canine small intestine. Life Sci 34: 1001–1006.
Fox JET, Daniel EE, Jury J, Robotham H (1985) Muscarinic inhibition of canine small intestinal motility in vivo. Am J Physiol (to be published).
Gilbert R, Rattan S, Goyal RK (1984) Pharmacologic identification, activation, and antagonism of two muscarinic receptor subtypes in the lower esophageal sphincter. J Pharmacol Exp Ther 230: 284–291.
Hammer R, Giachetti A (1982) Muscarinic receptor subtypes M1 and M2 biochemical and functional choracleugation. Life Sci 31: 2991–2998.
Mayer EA, Elashoff J, Walsh JH (1982) Characterization of bombesin effects on canine gastric muscle. Am J Physiol 243: G 141–G 147.
Sakai Y, Daniel EE, Jury J, Fox JET (1984) Neurotensin inhibition of canine intestinal motility in vivo via α-adrenoceptors. Can J Physiol Pharmacol 62: 403–411.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Fox, J.E.T., Daniel, E.E., McDonald, T.J. (1985). Peptidergic Activation of Muscarinic M1 Inhibition in the Canine Small Intestine in Vivo. In: Lux, G., Daniel, E.E. (eds) Muscarinic Receptor Subtypes in the GI Tract. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70668-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-70668-4_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70670-7
Online ISBN: 978-3-642-70668-4
eBook Packages: Springer Book Archive